Journey Medical (DERM) EBITDA Margin (2020)
Journey Medical's EBITDA Margin came in at -51.29% for FY2021, down 72.12 percentage points from 20.83% in FY2020.
Powered by 
Analysis
Journey Medical (DERM) EBITDA Margin (2020) Analysis & Trends
- Per Business Quant, earlier years put EBITDA Margin at 20.83% in FY2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 42.49% |
| 10 | Journey Medical | 123.72 Mn | 21.81 Mn | 12.37 Mn | - |
API Access
Journey Medical EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=DERM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "DERM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=DERM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();